Research ArticleBasic Science Investigations
The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
Alexander R. Haug, Ramona Cindea-Drimus, Christoph J. Auernhammer, Martin Reincke, Björn Wängler, Christopher Uebleis, Gerwin P. Schmidt, Burkhard Göke, Peter Bartenstein and Marcus Hacker
Journal of Nuclear Medicine September 2012, jnumed.111.101675; DOI: https://doi.org/10.2967/jnumed.111.101675
Alexander R. Haug
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
2Interdisciplinary Center of Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, Munich, Germany
Ramona Cindea-Drimus
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Christoph J. Auernhammer
2Interdisciplinary Center of Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, Munich, Germany
3Department of Internal Medicine 2, Ludwig-Maximilians-University of Munich, Munich, Germany
Martin Reincke
4Department of Medicine, University Hospital Innenstadt, Ludwig-Maximilians-University of Munich, Munich, Germany; and
Björn Wängler
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Christopher Uebleis
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Gerwin P. Schmidt
5Institute of Clinical Radiology, Ludwig-Maximilians-University of Munich, Munich, Germany
Burkhard Göke
2Interdisciplinary Center of Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, Munich, Germany
3Department of Internal Medicine 2, Ludwig-Maximilians-University of Munich, Munich, Germany
Peter Bartenstein
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
2Interdisciplinary Center of Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, Munich, Germany
Marcus Hacker
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
Alexander R. Haug, Ramona Cindea-Drimus, Christoph J. Auernhammer, Martin Reincke, Björn Wängler, Christopher Uebleis, Gerwin P. Schmidt, Burkhard Göke, Peter Bartenstein, Marcus Hacker
Journal of Nuclear Medicine Sep 2012, jnumed.111.101675; DOI: 10.2967/jnumed.111.101675
The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
Alexander R. Haug, Ramona Cindea-Drimus, Christoph J. Auernhammer, Martin Reincke, Björn Wängler, Christopher Uebleis, Gerwin P. Schmidt, Burkhard Göke, Peter Bartenstein, Marcus Hacker
Journal of Nuclear Medicine Sep 2012, jnumed.111.101675; DOI: 10.2967/jnumed.111.101675
Jump to section
Related Articles
Cited By...
- Primary neuroendocrine tumour of the extrahepatic biliary duct
- Dual Somatostatin Receptor/18F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors
- Quantitative 3D Assessment of 68Ga-DOTATOC PET/MRI with Diffusion-Weighted Imaging to Assess Imaging Markers for Gastroenteropancreatic Neuroendocrine Tumors: Preliminary Results
- Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms
- Pleuropulmonary tuberculosis with spinal lesions due to metastatic malignancy differentiated definitively on imaging
- The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
- 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients
- Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
- 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
- The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
- Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
- 64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
- Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
- GEP-NETS update: Functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs)
- Promises of Cyclotron-Produced 44Sc as a Diagnostic Match for Trivalent {beta}--Emitters: In Vitro and In Vivo Study of a 44Sc-DOTA-Folate Conjugate
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics